Pallas Health Review
Online GLP-1 and NAD+ care with bundled provider support, a $139 compounded-semaglutide first month, and a dedicated NAD+ program.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Quick Verdict
Pallas Health combines a polished bundled-care GLP-1 program with an uncommon NAD+ offering. It earns credit for stating its introductory and renewal pricing clearly, including the 12-week renewal cadence, and for listing both compounded and FDA-approved options. The headline introductory rate is not the long-term average, however, and the program is private pay. Consider Pallas if you value ongoing provider support, free shipping and the option to explore NAD+ alongside weight management; confirm the exact medication, quarterly renewal amount and state-specific visit requirements before enrolling.
- Provider care, messaging, shipping and dose adjustments included in the published plan price
- Compounded semaglutide first month from $139 and tirzepatide from $179
- Lists both compounded and FDA-approved GLP-1 options
- Dedicated NAD+ nasal-spray and injection program
- Compounded-program renewals are billed in 12-week intervals after the first month
- Private pay; insurance is not billed
- Compounded medications are not FDA-approved finished drugs
- Limited independent review history assessed for this initial review
Pallas Health Pricing
Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at Pallas Health.
| Program / Membership Fee | Included in plan price |
| Medication Cost (From) | From $139 – $299/mo |
Pallas advertises compounded semaglutide at $139 for the first month, then $597 every 12 weeks ($199/mo average), and compounded tirzepatide at $179 for the first month, then $897 every 12 weeks ($299/mo average). Prices include provider care; confirm the renewal charge and medication selection during intake.
Pallas Health Prices, Checked 15 August 2026
Billing every 12 weeks means $597 to $897 per renewal.
| Medication and dose or plan | Price |
|---|---|
Compounded semaglutide (injection) First month | $139/mointro |
Compounded semaglutide (injection) Then $597 every 12 weeks | $199/mo |
Compounded tirzepatide (injection) First month | $179/mointro |
Compounded tirzepatide (injection) Then $897 every 12 weeks | $299/mo |
- $199/mo for compounded semaglutide (injection): $597 every 12 weeks.
- $299/mo for compounded tirzepatide (injection): $897 every 12 weeks.
Read from Pallas Health's own pages on 15 August 2026: Pallas Health. Prices change often; confirm the total at checkout. Compare every provider in the GLP-1 price tracker.
Who Pallas Health Is For
Pallas Health suits adults who want online GLP-1 care with clinician review, ongoing care-team support and a single published price that includes provider care, messaging and shipping. Its weight-loss program lists both FDA-approved branded GLP-1s and compounded semaglutide or tirzepatide when a clinician determines treatment is appropriate. The first-month compounded prices are relatively clear: $139 for semaglutide and $179 for tirzepatide. The important renewal detail is that subsequent compounded refills are billed every 12 weeks, equivalent to $199/mo and $299/mo on average, respectively. Pallas also offers clinician-prescribed NAD+ nasal spray and injection programs, making it a broader option than a GLP-1-only clinic. It is less suitable for patients who want insurance billing or a simple ongoing one-month refill structure after the introductory period.
Adults seeking online GLP-1 care with clinician review, bundled provider support and brand-name or compounded options when clinically appropriate.
Signature Programs
- ›Compounded semaglutide and tirzepatide plans
- ›FDA-approved Wegovy, Zepbound, Ozempic and Mounjaro options
- ›NAD+ nasal spray and injection programs
- ›Provider care, check-ins and shipping included
Medication Formulary
How Pallas Health Scores
Pallas Health scores 4.1 / 5 overall (cost 4.0, experience 4.2, trust 3.8), which makes it one of the specialty options in the GLP-1 weight loss category we cover.
See how Pallas Health compares in our full GLP-1 weight loss rankings, or read the Best Telehealth GLP-1 Providers guide. Our methodology explains how we score each provider.
Frequently Asked Questions
How much does Pallas Health cost per month?
Pallas Health's published pricing runs $139 to $299 per month. Pallas advertises compounded semaglutide at $139 for the first month, then $597 every 12 weeks ($199/mo average), and compounded tirzepatide at $179 for the first month, then $897 every 12 weeks ($299/mo average). Prices include provider care; confirm the renewal charge and medication selection during intake. Confirm the all-in monthly total at checkout, because telehealth pricing changes without notice.
Does Pallas Health charge more as your GLP-1 dose increases?
Pallas Health publishes a bundled monthly price ($139 to $299 per month). The top of that range generally reflects higher doses or brand-name options, so check which tier your maintenance dose falls into.
What medications does Pallas Health prescribe?
Pallas Health lists compounded semaglutide, compounded tirzepatide, Wegovy, among others. It also prescribes FDA-approved brand-name medications including Wegovy, Zepbound, Ozempic. What you are prescribed depends on the clinician's assessment and your state.
Is Pallas Health legit?
Pallas Health connects patients with licensed clinicians for GLP-1 weight loss care. We score its trust and transparency at 3.8/5. Before ordering, check that the clinician is licensed in your state and, for compounded drugs, which pharmacy fills the prescription.
Can I cancel Pallas Health anytime?
Most telehealth plans, Pallas Health's included, are cancelled through the patient portal or support team, but refund terms vary. Compounded medication is made to order, so shipments are usually non-refundable once dispensed. Read the current terms before your first refill date to avoid an unwanted renewal.
- Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss versus 2.4% with placebo at 68 weeks in the STEP 1 trial.
- Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss versus 3.1% with placebo at 72 weeks in SURMOUNT-1.
- Lincoff et al., NEJM 2023 (SELECT) · In adults with overweight or obesity and established cardiovascular disease, semaglutide 2.4 mg reduced major adverse cardiovascular events in the SELECT trial.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.
Alternatives To Pallas Health
Also Competes With
Pallas Health also operates in Longevity & NAD+. Here are other providers in those spaces: